Chemical Formula: C14H22N2O3

Chemical Formula C14H22N2O3

Found 30 metabolite its formula value is C14H22N2O3

Practolol

N-[4-[(2S)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide

C14H22N2O3 (266.16303419999997)


Practolol is only found in individuals that have used or taken this drug. It is a beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias. [PubChem]Like other beta-adrenergic antagonists, practolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, practolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Same as: D05587 Practolol is a potent and selective β1-adrenergic receptor antagonist. Practolol can be used for the research of cardiac arrhythmias[1][2][3].

   

atenolol

(±)-2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide

C14H22N2O3 (266.16303419999997)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; INTERNAL_ID 4076 CONFIDENCE Reference Standard (Level 1) CONFIDENCE standard compound; INTERNAL_ID 1106 Atenolol ((RS)-Atenolol) is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at β1-adrenoceptor in guine pig left ventricle membrane. Atenolol can be used for the research of hypertension and angina pectoris[1][2].

   

Atenolol

(±)-2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide

C14H22N2O3 (266.16303419999997)


Atenolol is a so-called beta1-selective (or cardioselective) drug. That means that it exerts greater blocking activity on myocardial beta1-receptors than on beta2 ones in the lung. The beta2 receptors are responsible to keep the bronchial system open. If these receptors are blocked, bronchospasm with serious lack of oxygen in the body can result. However, due to its cardioselective properties, the risk of bronchospastic reactions if using atenolol is reduced compared to nonselective drugs as propranolol. Nonetheless, this reaction may also be encountered with atenolol, particularly with high doses. Extreme caution should be exerted if atenolol is given to asthma patients, who are particularly at risk; the dose should be as low as possible. If an asthma attack occurs, the inhalation of a beta2-mimetic antiasthmatic, such as hexoprenalin or salbutamol, will usually suppress the symptoms.; Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases such as hypertension, coronary heart disease, arrhythmias, and treatment of myocardial infarction after the acute event. Patients with compensated congestive heart failure may be treated with atenolol as a co medication (usually together with an ACE inhibitor, a diuretic and a digitalis-glycoside, if indicated). In patients with congestive heart failure, it reduces the need for and the consumption of oxygen of the heart muscle. It is very important to start with low doses, as atenolol reduces also the muscular power of the heart, which is an undesired effect in congestive heart failure. [HMDB] Atenolol is a so-called beta1-selective (or cardioselective) drug. That means that it exerts greater blocking activity on myocardial beta1-receptors than on beta2 ones in the lung. The beta2 receptors are responsible to keep the bronchial system open. If these receptors are blocked, bronchospasm with serious lack of oxygen in the body can result. However, due to its cardioselective properties, the risk of bronchospastic reactions if using atenolol is reduced compared to nonselective drugs as propranolol. Nonetheless, this reaction may also be encountered with atenolol, particularly with high doses. Extreme caution should be exerted if atenolol is given to asthma patients, who are particularly at risk; the dose should be as low as possible. If an asthma attack occurs, the inhalation of a beta2-mimetic antiasthmatic, such as hexoprenalin or salbutamol, will usually suppress the symptoms. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases such as hypertension, coronary heart disease, arrhythmias, and treatment of myocardial infarction after the acute event. Patients with compensated congestive heart failure may be treated with atenolol as a co medication (usually together with an ACE inhibitor, a diuretic and a digitalis-glycoside, if indicated). In patients with congestive heart failure, it reduces the need for and the consumption of oxygen of the heart muscle. It is very important to start with low doses, as atenolol reduces also the muscular power of the heart, which is an undesired effect in congestive heart failure. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Atenolol ((RS)-Atenolol) is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at β1-adrenoceptor in guine pig left ventricle membrane. Atenolol can be used for the research of hypertension and angina pectoris[1][2].

   

Bucolome

5-butyl-3-cyclohexyl-6-hydroxy-2,3,4,5-tetrahydropyrimidine-2,4-dione

C14H22N2O3 (266.16303419999997)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

CC(=O)Nccccccn1C=CC(=O)C(O)=C1C

N-[6-(3-Hydroxy-2-methyl-4-oxo-1,4-dihydropyridin-1-yl)hexyl]ethanimidate

C14H22N2O3 (266.16303419999997)


   

Dilatan

Biopharma brand OF trimetazidine dihydrochloride

C14H22N2O3 (266.16303419999997)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C - Cardiovascular system > C01 - Cardiac therapy Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

atenolol

(±)-2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide

C14H22N2O3 (266.16303419999997)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 169 Atenolol ((RS)-Atenolol) is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM at β1-adrenoceptor in guine pig left ventricle membrane. Atenolol can be used for the research of hypertension and angina pectoris[1][2].

   

TRIMETAZIDINE

TRIMETAZIDINE

C14H22N2O3 (266.16303419999997)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C - Cardiovascular system > C01 - Cardiac therapy Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1-(2-methoxyphenoxy)-3-piperazin-1-ylpropan-2-ol

1-(2-methoxyphenoxy)-3-piperazin-1-ylpropan-2-ol

C14H22N2O3 (266.16303419999997)


   
   

(S)-N-(Butoxycarbonyl)-4-aminophenylalaninol

(S)-N-(Butoxycarbonyl)-4-aminophenylalaninol

C14H22N2O3 (266.16303419999997)


   

3-(N,N-Dimethoxyethyl)amino acetanilide

3-(N,N-Dimethoxyethyl)amino acetanilide

C14H22N2O3 (266.16303419999997)


   

1-[(2,4,6-Trimethoxyphenyl)methyl]piperazine dihydrochloride

1-[(2,4,6-Trimethoxyphenyl)methyl]piperazine dihydrochloride

C14H22N2O3 (266.16303419999997)


   

[2-amino-2-(3-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester

[2-amino-2-(3-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester

C14H22N2O3 (266.16303419999997)


   

(R)-(+)-Atenolol

(R)-(+)-Atenolol

C14H22N2O3 (266.16303419999997)


(R)-(+)-Atenolol is the less active enantiomer of the (R,S)-atenolol. (R,S)-atenolol is a β-adrenergic receptor antagonist[1][2].

   

3-AMINO-3-[4-(3-DIMETHYLAMINO-PROPOXY)-PHENYL]-PROPIONIC ACID

3-AMINO-3-[4-(3-DIMETHYLAMINO-PROPOXY)-PHENYL]-PROPIONIC ACID

C14H22N2O3 (266.16303419999997)


   

esatenolol

Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (S)-

C14H22N2O3 (266.16303419999997)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

[2-amino-2-(2-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester hydrochloride

[2-amino-2-(2-methoxy-phenyl)-ethyl]-carbamic acid tert-butyl ester hydrochloride

C14H22N2O3 (266.16303419999997)


   

TERT-BUTYL 2-(AMINOMETHYL)-4-METHOXYBENZYLCARBAMATE

TERT-BUTYL 2-(AMINOMETHYL)-4-METHOXYBENZYLCARBAMATE

C14H22N2O3 (266.16303419999997)


   
   

(S)-1-(3-(Ethyl(methyl)carbamoyloxy)phenyl)-N,N-dimethylethanamine oxide

(S)-1-(3-(Ethyl(methyl)carbamoyloxy)phenyl)-N,N-dimethylethanamine oxide

C14H22N2O3 (266.16303419999997)


   

1-[(3,4,5-Trimethoxyphenyl)methyl]piperazine

1-[(3,4,5-Trimethoxyphenyl)methyl]piperazine

C14H22N2O3 (266.16303419999997)


   

1-(4-METHOXY-PHENOXY)-3-PIPERAZIN-1-YL-PROPAN-2-OL

1-(4-METHOXY-PHENOXY)-3-PIPERAZIN-1-YL-PROPAN-2-OL

C14H22N2O3 (266.16303419999997)


   
   

1-(2,4,5-Trimethoxybenzyl)piperazine

1-(2,4,5-Trimethoxybenzyl)piperazine

C14H22N2O3 (266.16303419999997)


   

4H-Pyrido(1,2-a)pyrimidine-3-carboxylic acid, 1,6,7,8,9,9a-hexahydro-1-ethyl-6-methyl-4-oxo-, ethyl ester

4H-Pyrido(1,2-a)pyrimidine-3-carboxylic acid, 1,6,7,8,9,9a-hexahydro-1-ethyl-6-methyl-4-oxo-, ethyl ester

C14H22N2O3 (266.16303419999997)


   

practolol

practolol

C14H22N2O3 (266.16303419999997)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Same as: D05587 Practolol is a potent and selective β1-adrenergic receptor antagonist. Practolol can be used for the research of cardiac arrhythmias[1][2][3].

   

Bucolome

Bucolome

C14H22N2O3 (266.16303419999997)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

(2R,3R,4S,5R)-2-({[(1R)-2-Hydroxy-1-phenylethyl]amino}methyl)-5-methylpyrrolidine-3,4-diol

(2R,3R,4S,5R)-2-({[(1R)-2-Hydroxy-1-phenylethyl]amino}methyl)-5-methylpyrrolidine-3,4-diol

C14H22N2O3 (266.16303419999997)


   

N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanamide

N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanamide

C14H22N2O3 (266.16303419999997)